Treatment options for nonresponders and relapsers to initial therapy for hepatitis C

Marten Duncan, DO
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, and the Department of
Gastroenterology, Walter Reed Army Medical Center, Washington, DC

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA

Correspondence: Zobair Younossi, MD, MPH, Director, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: zobair.younossi@inova.com

Marten Duncan, DO
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, and the Department of
Gastroenterology, Walter Reed Army Medical Center, Washington, DC

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA

Correspondence: Zobair Younossi, MD, MPH, Director, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: zobair.younossi@inova.com

Marten Duncan, DO
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, and the Department of
Gastroenterology, Walter Reed Army Medical Center, Washington, DC

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA

Correspondence: Zobair Younossi, MD, MPH, Director, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: zobair.younossi@inova.com